ELASTA-Clip followed by transapical TMVR is a less invasive Tx for patients with failed M-TEER, with encouraging early results in carefully selected Pts. Preventing PVL and stroke is crucial. Larger, long-term studies are needed @JACCJournals https://t.co/sEV2xplJtB

#EHJVSHD: a comprehensive review summarising diagnosis, management, and follow-up of #Bicuspid #AorticStenosis, with a specific focus on #SAVR and #TAVI approaches https://t.co/DGcTP6PXzF @MarcoMetra @PanichellaG @hahn_rt @EHJVSHDEiC

The extent of cardiac damage significantly affects 10-year survival of patients with moderate and severe aortic stenosis. Cardiac damage staging might be as important as aortic stenosis grading in defining the prognosis of patients with aortic stenosis. https://t.co/BMu2HmsuLI

What a great beginning for our new journal! The first article in #EHJVSHD sets the standard high for what’s to come - a comprehensive review on bicuspid aortic stenosis and its management Don’t miss it 🔗 https://t.co/RtqYOIhxF8 #VHD #AorticStenosis

NEW: We’re honoured to be ranked number one in the @timeshighered World University Rankings for the tenth consecutive year. 👏

Multicenter evaluation of self-expanding intra-annular #TAVR in severe calcified aortic valves ✅ Key insights 👉 https://t.co/3B71raUVvc Grateful for the outstanding mentorship of @AnderRegueiro 🚀 and the collaboration of @drgocchipinti @hospitalclinic @CJCJournals

Is the Cx ostium still the Achilles heel of LM bifurcation PCI? Our analysis from the EBC MAIN trial is now published in @CircIntv The Cx ostium was the commonest site requiring revascularization after LM bifurcation PCI, irrespective of whether one or two stents had been

Does excessive aortic cusp calcification change the risk–benefit balance between self-expanding and balloon-expandable TAVR? Our new study dives into peri-procedural and long-term outcomes. https://t.co/yxtn4yCici #TAVR @ThomPilgrim @BashirAlaour @taishiokuno @DaryoushSamim

Procedural factors determine transcatheter aortic valve performance. The CODE framework integrates key parameters to systematically optimize TAVR outcomes. https://t.co/tShLeOxMMM @JACCJournals @DomAngellotti

TRISCEND II subanalysis showed greater benefit of TTVR in massive/torrential TR, suggesting this may be the target population ( https://t.co/OLkOdJCnH4). In our paper just published, massive/torrential TR did not reduce TTVI eligibility vs severe TR ( https://t.co/s8wVRaNOH3)

Are you performing right cath after TTVR? EJHF: First insights into the impact of TR elimination on right heart: Immediate RAP reduction ⬇️ Increased systolic RV/PA pressure⬆️ and PAPi ⬆️ Data From Bern by Fabien Praz 🔗 https://t.co/W0gxh7CxyR @EJHFEiC #CardioTwitter

‼️ Periprocedural treatment with colchicine may reduce the incidence of new-onset arrhythmias and subclinical leaflet thrombosis after #TAVR 📊 Check out the results of the Co-STAR trial: https://t.co/0RNPosXgxh

Non-coaxial transcatheter aortic valve deployment relative to the native annulus is associated with impaired valve early safety and increased risk of bioprosthetic valve failure 1 year after TAVR. https://t.co/zIezMCahf8

Honored to share the updated #TAVI chapter in the official PCR-EAPCI Textbook! 📖 🎯 For SHD newcomers & veterans alike — a resource to support your clinical and research journey. 📊 50+ visuals covering: 🔹AS pathophys 🔹Landmark trials 🔹TAVI strategy 🔹Lifetime management

📢🆕 #SCAITTEERebook highlight – Ch 1: #TR is often detected late due to nonspecific symptoms. This ebook reviews TR’s causes, indicators, and chronic symptoms, exploring classifications of severe TR: primary, secondary, and #CIED lead-related. 🫀Read the ebook 📖 🔗

📢🆕 #SCAITTEERebook Highlight – Section 1: Chapters 1-5 provide a comprehensive overview of clinical evaluation and imaging techniques for #TR. It covers clinical presentation, evaluation methods using #TTE and #TEE, and hemodynamic assessment. Emphasizing early referral to

« Survival in the wealthiest U.S. quartile appeared to be similar to that in the poorest quartile in northern and western Europe. » @idriss_samim @DavidTeurtrie @ToddVousGuette @alancelin @FPopMedia

Excited to share our latest review on imaging in TR and more! Grateful to @hahn_rt and @JoaoLCavalcante for the opportunity to contribute to this important project. #ACC25 #JACCIMG

📕Take a look at our chapter on the presentation and clinical evaluation of TR, a crucial step towards a possible transcatheter treatment such as T-TEER. 🌐The eBook on T-TEER is free to access with an @SCAI login: https://t.co/T9f6VuK34L @FabienPraz

Double Transcatheter AV Replacement: •A staged transcatheter Tx offers a promising strategy for surgical high risk patients with multi valvular heart disease (VHD) •Further evidence from RCT is needed for the transcatheter Tx of multi VHD https://t.co/D5CJRdzh5p

Cardiac involvement is frequent in newly Dx TB pts. Early pericardial changes may be reversed w/ anti-TB Tx. Echocardiographic screening facilitates early detection & timely management of CV involvement in TB pts. https://t.co/aUAbcPB5TJ #JACCAdvances #Tuberculosis @DaryoushSamim